Jul 19, 2021
Professor Nikolai Petrovsky graduated from Medicine at the University of Tasmania in 1982. He then went on to do his Fellowship specialising in Endocrinology. Not stopping there, he completed a PhD in Immunology at the Walter & Eliza Hall institute in Melbourne, one of the world’s leading Immunology research centres. In addition to being an active clinician, Nikolai is a Professor of Medicine at Flinders University and Chairman and Research director of Vaxine Pty Ltd, an Adelaide-based biotechnology company focused on vaccine development. Over the last 18 years he has been awarded over $50 million dollars in vaccine research grants including multiple grants from the US government’s National Institutes of Health. He has authored over 200 peer-reviewed research papers and has won many prestigious awards including Ernst & Young Entrepreneur of the Year Award in 2010 and Asian Executive of the Year award in 2011. His current focus is completing development of his company’s protein-based vaccine against COVID-19 that is just entering final Phase 3 clinical trials and is expected to be approved overseas before the end of 2021.